Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
ASAIO J ; 59(3): 331-5, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23644626

RESUMO

Respiratory failure requiring intubation has traditionally been a relative contraindication to lung transplantation due to increased morbidity and mortality. Advances in extracorporeal membranous oxygenation (ECMO) have made it possible to extubate patients and provide physical therapy with minimal native lung function. By "bridging" patients to lung transplant using ECMO, they are able to undergo rehabilitation and withstand the demands of surgery. However, providing anesthesia for these cases requires an understanding of ECMO physiology and the pharmacology associated with ECMO. We describe the anesthetic for four patients who were bridged to lung transplant and the complexities of their perioperative management.


Assuntos
Oxigenação por Membrana Extracorpórea/métodos , Transplante de Pulmão/métodos , Assistência Perioperatória/métodos , Insuficiência Respiratória/terapia , Adulto , Humanos , Masculino , Pessoa de Meia-Idade , Insuficiência Respiratória/fisiopatologia , Insuficiência Respiratória/cirurgia , Resultado do Tratamento
2.
Clin Cardiol ; 31(1): 6-10, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-17847039

RESUMO

Atrial fibrillation (AF) usually develops within the first 72 h following cardiac surgery, and is often self-limiting. Within 48 h of acute onset of symptoms, approximately 50% of patients spontaneously convert to normal sinus rhythm. Thus, the relative risks and benefits of therapy must be carefully considered. The etiology of AF following cardiac surgery is similar to that in non-surgical patients except that pericardial inflammation and increased adrenergic tone play an increasingly important role. Further, AF after surgery may be associated with transient risk factors that resolve as the patient moves out from surgery, and the condition is less likely to recur compared to AF arising in other circumstances. Immediate heart rate control is important in preventing ischemia, tachycardia-induced cardiomyopathy, and left ventricular dilatation. At our institution, amiodarone is frequently used as a first-line drug for treating AF after cardiac surgery. Inconsistent prescribing practices, variable dosage regimens, and a lack of consensus regarding the appropriate use of amiodarone prompted the need for developing practice guidelines. Multidisciplinary collaboration between the departments of cardiac surgery, pharmacy, and anesthesiology led to the development of a protocol for postoperative AF. We review the clinical evidence from published trials and discuss our guidelines, defining amiodarone use for AF in the cardiac surgery setting.


Assuntos
Amiodarona/uso terapêutico , Antiarrítmicos/uso terapêutico , Fibrilação Atrial/tratamento farmacológico , Procedimentos Cirúrgicos Cardíacos/efeitos adversos , Hospitais Universitários , Guias de Prática Clínica como Assunto , Fibrilação Atrial/etiologia , Seguimentos , Humanos , Complicações Pós-Operatórias
3.
Crit Care ; 7(5): 335-8, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12974961

RESUMO

Intensivists have the potential to maintain vital signs almost indefinitely, but not necessarily the potential to make moribund patients whole. Current ethical and legal mandates push patient autonomy to the forefront of care plans. When patients are incapable of expressing their preferences, surrogates are given proxy. It is unclear how these preferences extend to the very brink of inevitable death. Some say that patients should have the opportunity and authority to direct their death spiral. Others say it would be impossible for them to do so because an inevitable death spiral cannot be effectively palliated. Humane principles dictate they be spared the unrelenting discomfort surrounding death. The present case examines such a patient and the issues surrounding a unique end-of-life decision.


Assuntos
Relações Familiares , Unidades de Terapia Intensiva/ética , Cuidados para Prolongar a Vida/ética , Doente Terminal , Revelação da Verdade/ética , Beneficência , Humanos , Hipnóticos e Sedativos/administração & dosagem , Masculino , Futilidade Médica , Pessoa de Meia-Idade , Prognóstico , Propofol/administração & dosagem , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...